Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
Vaccine panel chairman, pediatric cardiologist Kirk Milhoan, M.D., is on solid ground scientifically and ethically, state physicians, in requiring consent
-
Aquaculture Vaccine Market Set to Nearly Double by 2033, Driven by Rising Disease Prevention Efforts
Dublin, Jan. 19, 2026 (GLOBE NEWSWIRE) -- The "Aquaculture Vaccines Market Size, Share & Trends Analysis Report by Product (Attenuated Live Vaccines, Inactivated Vaccines), Route of...
-
Washington, DC, Jan. 14, 2026 (GLOBE NEWSWIRE) -- The Asthma and Allergy Foundation of America (AAFA) announces the release of a new COVID-19 Vaccine Decision Aid, designed to help people...
-
Statement from Unity Consortium on Announced Changes to the U.S. Childhood and Adolescent Immunization Schedule
-
Washington, DC, Jan. 08, 2026 (GLOBE NEWSWIRE) -- On January 5, 2026, under Health and Human Services Secretary Kennedy’s leadership, the Centers for Disease Control and Prevention (CDC) released...
-
Washington, DC, Jan. 08, 2026 (GLOBE NEWSWIRE) -- On January 5, 2026, under Health and Human Services Secretary Kennedy’s leadership, the Centers for Disease Control and Prevention (CDC) released...
-
BRISBANE, Australia and CAMBRIDGE, Mass., Jan. 07, 2026 (GLOBE NEWSWIRE) -- Vaxxas Pty Ltd today announced the appointment of global biopharmaceutical executive Mr David Peacock as Chief Executive...
-
STOCKHOLM, 22 december 2025. Karolinska Development AB (Nasdaq Stockholm: KDEV) meddelar idag att portföljbolaget SVF Vaccines AB har ingått en icke-bindande avsiktsförklaring med Novakand Pharma AB...
-
STOCKHOLM, Sweden, December 22, 2025. Karolinska Development AB (Nasdaq Stockholm: KDEV) announces that its portfolio company SVF Vaccines has signed a non-binding letter of intent (LOI) with Novakand...
-
BRISBANE, Australia and CAMBRIDGE, Mass., Dec. 14, 2025 (GLOBE NEWSWIRE) -- Australian biotechnology pioneer Vaxxas Pty Ltd, has been granted a licence by the Therapeutic Goods Administration...